インドの糖尿病市場は2020年から2024年にかけて力強い成長を遂げ、年平均成長率（CAGR）7.7%を達成しました。この上昇傾向は今後も続くと予想され、2025年から2029年にかけては6.1%の年平均成長率（CAGR）で成長すると予測されています。2029年末までに、糖尿病市場は2024年の32億8,430万米ドルから約47億7,170万米ドルに拡大すると予測されています。
インドの糖尿病装置および治療薬市場は、CGMの普及拡大、デジタルヘルスの統合強化、治療薬デリバリーシステムの進歩、そして規制枠組みの進化によって再編されつつあります。これらのトレンドは今後2〜4年でさらに加速し、患者モニタリングの改善、より正確な治療調整、そして市場全体の拡大につながると予想されます。
インドの糖尿病装置および治療市場は、多国籍企業と新興国内企業がダイナミックに混在する状況にあります。近年の戦略的提携、合併、買収により競争環境は大きく変化しており、デジタル統合と規制の整合性がますます重視されています。今後数年間は、競争の激化と戦略的な統合により、インド全土でイノベーションが促進され、患者管理が強化されると予想されます。
インド市場は、糖尿病ケア分野において多国籍企業と国内のイノベーターが混在しています。多様な償還経路を備えた多層的な医療システムは、既存企業と新興企業の両方にビジネスチャンスをもたらします。
本レポートは、インドの糖尿病業界に関する詳細なデータ中心の分析を提供し、診断・モニタリング機器、治療薬、領域など、幅広い分野にわたる市場機会と分析を網羅しています。国レベルで50以上のKPIを網羅した本レポートは、糖尿病市場のダイナミクス、市場規模と予測、そして市場シェア統計に関する包括的な理解を提供します。
BioIntel360の調査手法は、業界のベストプラクティスに基づいています。独自の分析プラットフォームを活用した公平な分析により、新興ビジネスおよび投資市場の機会に関する詳細な見解を提供します。
本レポートは、2020年から2029年にかけてのインドの糖尿病関連機器および治療薬市場について、データに基づいた詳細な分析を提供しています。主要な市場セグメントの概要は以下のとおりです。
目次
Table of Contents
1 India Diabetes Devices and Therapeutics Market Size and Forecast, 2020-2029
2 India Diabetes Devices and Therapeutics Market Share by Category, 2020-2029
2.1 India Diabetes Devices and Therapeutics Market Size by Diagnosis and Monitoring Devices, 2020-2029
2.2 India Diabetes Devices and Therapeutics Market Size by Therapeutics, 2020-2029
3 India Diabetes Devices and Therapeutics Market Share by Diagnosis and Monitoring Devices, 2020-2029
3.1 Diabetes Devices and Therapeutics Market Size by Blood Glucose Monitoring Devices, 2020-2029
3.2 Diabetes Devices and Therapeutics Market Size by Insulin Delivery Devices, 2020-2029
3.3 Diabetes Devices and Therapeutics Market Size by Diabetes Management and Mobile Applications, 2020-2029
3.4 Diabetes Devices and Therapeutics Market Size by Artificial Pancreas Devices, 2020-2029
4 India Diabetes Devices and Therapeutics Market Share by Blood Glucose Monitoring Devices, 2020-2029
4.1 Diabetes Devices and Therapeutics Market Size by Self-Monitoring Blood Glucose Devices, 2020-2029
4.2 Diabetes Devices and Therapeutics Market Size by Continuous Blood Glucose Monitoring Devices, 2020-2029
4.3 Diabetes Devices and Therapeutics Market Size by Test Strips, 2020-2029
4.4 Diabetes Devices and Therapeutics Market Size by Lancets, 2020-2029
5 India Diabetes Devices and Therapeutics Market Share by Insulin Delivery Devices, 2020-2029
5.1 Diabetes Devices and Therapeutics Market Size by Insulin Pumps, 2020-2029
5.2 Diabetes Devices and Therapeutics Market Size by Insulin Pens, 2020-2029
5.3 Diabetes Devices and Therapeutics Market Size by Insulin Syringes, 2020-2029
6 India Diabetes Devices and Therapeutics Market Share by Therapeutics, 2020-2029
6.1 Diabetes Devices and Therapeutics Market Size by Oral Anti-Diabetic Drugs, 2020-2029
6.2 Diabetes Devices and Therapeutics Market Size by Insulin, 2020-2029
6.3 Diabetes Devices and Therapeutics Market Size by Non-Insulin Injectable Drugs, 2020-2029
6.4 Diabetes Devices and Therapeutics Market Size by Combination Drugs, 2020-2029
7 India Diabetes Devices and Therapeutics Market Share by Oral Anti-Diabetic Drugs, 2020-2029
7.1 Diabetes Devices and Therapeutics Market Size by Alpha-Glucosidase Inhibitors, 2020-2029
7.2 Diabetes Devices and Therapeutics Market Size by DPP-4 Inhibitors, 2020-2029
7.3 Diabetes Devices and Therapeutics Market Size by SGLT-2 Inhibitors, 2020-2029
8 India Diabetes Devices and Therapeutics Market Share by Insulin, 2020-2029
8.1 Diabetes Devices and Therapeutics Market Size by Basal or Long-Acting, 2020-2029
8.2 Diabetes Devices and Therapeutics Market Size by Bolus or Fast-Acting, 2020-2029
8.3 Diabetes Devices and Therapeutics Market Size by Traditional Human Insulin Drugs, 2020-2029
8.4 Diabetes Devices and Therapeutics Market Size by Insulin Biosimilars, 2020-2029
9 India Diabetes Devices and Therapeutics Market Share by Non-Insulin Injectable Drugs, 2020-2029
9.1 Diabetes Devices and Therapeutics Market Size by GLP-1 Receptor Agonists, 2020-2029
9.2 Diabetes Devices and Therapeutics Market Size by Amylin Analogue, 2020-2029
10 India Diabetes Devices and Therapeutics Market Share by Combination Drugs, 2020-2029
10.1 Diabetes Devices and Therapeutics Market Size by Combination Insulin, 2020-2029
10.2 Diabetes Devices and Therapeutics Market Size by Oral Combination, 2020-2029
11 India Diabetes Devices and Therapeutics Market Share by Route of Administration, 2020-2029
11.1 Diabetes Devices and Therapeutics Market Size by Subcutaneous, 2020-2029
11.2 Diabetes Devices and Therapeutics Market Size by Intravenous, 2020-2029
11.3 Diabetes Devices and Therapeutics Market Size by Others, 2020-2029
12 India Diabetes Devices and Therapeutics Market Share by Type of Diabetes, 2020-2029
12.1 Diabetes Devices and Therapeutics Market Size by Type 2 Diabetes, 2020-2029
12.2 Diabetes Devices and Therapeutics Market Size by Type 1 Diabetes, 2020-2029
13 India Diabetes Devices and Therapeutics Market Share by Distribution Channels, 2020-2029
13.1 Diabetes Devices and Therapeutics Market Size by Online Pharmacies, 2020-2029
13.2 Diabetes Devices and Therapeutics Market Size by Hospital Pharmacies, 2020-2029
13.3 Diabetes Devices and Therapeutics Market Size by Retail Pharmacies, 2020-2029
14 India Diabetes Devices and Therapeutics Market Share by End User, 2020-2029
14.1 Diabetes Devices and Therapeutics Market Size by Hospitals, 2020-2029
14.2 Diabetes Devices and Therapeutics Market Size by Diabetes Clinics, 2020-2029
14.3 Diabetes Devices and Therapeutics Market Size by Homecare, 2020-2029
List of Tables
Table 1: India Diabetes Devices and Therapeutics Market Size by Value (US$ Million) 2020-2029
Table 2: India Diabetes Devices and Therapeutics Market Size by Diagnosis and Monitoring Devices, by Value (US$ Million), 2020-2029
Table 3: India Diabetes Devices and Therapeutics Market Size by Therapeutics, by Value (US$ Million) 2020-2029
Table 4: India Diabetes Devices and Therapeutics Market Size by Blood Glucose Monitoring Devices, by Value (US$ Million) 2020-2029
Table 5: India Diabetes Devices and Therapeutics Market Size by Insulin Delivery Devices, by Value (US$ Million) 2020-2029
Table 6: India Diabetes Devices and Therapeutics Market Size by Diabetes Management and Mobile Applications, by Value (US$ Million) 2020-2029
Table 7: India Diabetes Devices and Therapeutics Market Size by Artificial Pancreas Devices, by Value (US$ Million) 2020-2029
Table 8: India Diabetes Devices and Therapeutics Market Size by Self-Monitoring Blood Glucose Devices, by Value (US$ Million) 2020-2029
Table 9: India Diabetes Devices and Therapeutics Market Size by Continuous Blood Glucose Monitoring Devices, by Value (US$ Million) 2020-2029
Table 10: India Diabetes Devices and Therapeutics Market Size by Test Strips, by Value (US$ Million) 2020-2029
Table 11: India Diabetes Devices and Therapeutics Market Size by Lancets, by Value (US$ Million) 2020-2029
Table 12: India Diabetes Devices and Therapeutics Market Size by Insulin Pumps, by Value (US$ Million) 2020-2029
Table 13: India Diabetes Devices and Therapeutics Market Size by Insulin Pens, by Value (US$ Million) 2020-2029
Table 14: India Diabetes Devices and Therapeutics Market Size by Insulin Syringes, by Value (US$ Million) 2020-2029
Table 15: India Diabetes Devices and Therapeutics Market Size by Oral Anti-Diabetic Drugs, by Value (US$ Million), 2020-2029
Table 16: India Diabetes Devices and Therapeutics Market Size by Insulin, by Value (US$ Million), 2020-2029
Table 17: India Diabetes Devices and Therapeutics Market Size by Non-Insulin Injectable Drugs, by Value (US$ Million), 2020-2029
Table 18: India Diabetes Devices and Therapeutics Market Size by Combination Drugs, by Value (US$ Million), 2020-2029
Table 19: India Diabetes Devices and Therapeutics Market Size by Alpha-Glucosidase Inhibitors (US$ Million), 2020-2029
Table 20: India Diabetes Devices and Therapeutics Market Size by DPP-4 Inhibitors (US$ Million), 2020-2029
Table 21: India Diabetes Devices and Therapeutics Market Size by SGLT-2 Inhibitors (US$ Million), 2020-2029
Table 22: India Diabetes Devices and Therapeutics Market Size by Basal or Long-Acting, by Value (US$ Million), 2020-2029
Table 23: India Diabetes Devices and Therapeutics Market Size by Bolus or Fast-Acting, by Value (US$ Million), 2020-2029
Table 24: India Diabetes Devices and Therapeutics Market Size by Traditional Human Insulin Drugs, by Value (US$ Million), 2020-2029
Table 25: India Diabetes Devices and Therapeutics Market Size by Insulin Biosimilars, by Value (US$ Million), 2020-2029
Table 26: India Diabetes Devices and Therapeutics Market Size by GLP-1 Receptor Agonists, by Value (US$ Million), 2020-2029
Table 27: India Diabetes Devices and Therapeutics Market Size by Amylin Analogue, by Value (US$ Million), 2020-2029
Table 28: India Diabetes Devices and Therapeutics Market Size by Combination Insulin, by Value (US$ Million), 2020-2029
Table 29: India Diabetes Devices and Therapeutics Market Size by Oral Combination, by Value (US$ Million), 2020-2029
Table 30: India Diabetes Devices and Therapeutics Market Size by Subcutaneous, by Value (US$ Million), 2020-2029
Table 31: India Diabetes Devices and Therapeutics Market Size by Intravenous, by Value (US$ Million), 2020-2029
Table 32: India Diabetes Devices and Therapeutics Market Size by Others, by Value (US$ Million), 2020-2029
Table 33: India Diabetes Devices and Therapeutics Market Size by Type 2 Diabetes, by Value (US$ Million), 2020-2029
Table 34: India Diabetes Devices and Therapeutics Market Size by Type 1 Diabetes, by Value (US$ Million), 2020-2029
Table 35: India Diabetes Devices and Therapeutics Market Size by Online Pharmacies, by Value (US$ Million), 2020-2029
Table 36: India Diabetes Devices and Therapeutics Market Size by Hospital Pharmacies, by Value (US$ Million), 2020-2029
Table 37: India Diabetes Devices and Therapeutics Market Size by Retail Pharmacies, by Value (US$ Million), 2020-2029
Table 38: India Diabetes Devices and Therapeutics Market Size by Hospitals, by Value (US$ Million), 2020-2029
Table 39: India Diabetes Devices and Therapeutics Market Size by Diabetes Clinics, by Value (US$ Million), 2020-2029
Table 40: India Diabetes Devices and Therapeutics Market Size by Homecare, by Value (US$ Million), 2020-2029
List of Figures
Figure 1: India Diabetes Devices and Therapeutics Market Size by Value (US$ Million) 2020-2029
Figure 2: India Diabetes Devices and Therapeutics Market Share by Category (%), 2020-2029
Figure 3: India Diabetes Devices and Therapeutics Market Size by Diagnosis and Monitoring Devices, by Value (US$ Million), 2020-2029
Figure 4: India Diabetes Devices and Therapeutics Market Size by Therapeutics, by Value (US$ Million) 2020-2029
Figure 5: India Diabetes Devices and Therapeutics Market Share by Diagnosis and Monitoring Devices (%), 2020-2029
Figure 6: India Diabetes Devices and Therapeutics Market Size by Blood Glucose Monitoring Devices, by Value (US$ Million) 2020-2029
Figure 7: India Diabetes Devices and Therapeutics Market Size, by Insulin Delivery Devices, by Value (US$ Million) 2020-2029
Figure 8: India Diabetes Devices and Therapeutics Market Size by Diabetes Management and Mobile Applications, by Value (US$ Million) 2020-2029
Figure 9: India Diabetes Devices and Therapeutics Market Size, by Artificial Pancreas Devices, by Value (US$ Million) 2020-2029
Figure 10: India Diabetes Devices and Therapeutics Market Share by Blood Glucose Monitoring Devices (%), 2020-2029
Figure 11: India Diabetes Devices and Therapeutics Market Size by Self-Monitoring Blood Glucose Devices, by Value (US$ Million) 2020-2029
Figure 12: India Diabetes Devices and Therapeutics Market Size by Continuous Blood Glucose Monitoring Devices, by Value (US$ Million) 2020-2029
Figure 13: India Diabetes Devices and Therapeutics Market Size by Test Strips, by Value (US$ Million) 2020-2029
Figure 14: India Diabetes Devices and Therapeutics Market Size by Lancets, by Value (US$ Million) 2020-2029
Figure 15: India Diabetes Devices and Therapeutics Market Share by Insulin Delivery Devices (%), 2020-2029
Figure 16: India Diabetes Devices and Therapeutics Market Share by Insulin Pumps, by Value (US$ Million) 2020-2029
Figure 17: India Diabetes Devices and Therapeutics Market Share by Insulin Pens, by Value (US$ Million) 2020-2029
Figure 18: India Diabetes Devices and Therapeutics Market Share by Insulin Syringes, by Value (US$ Million) 2020-2029
Figure 19: India Diabetes Devices and Therapeutics Market Share by Therapeutics (%), 2020-2029
Figure 20: India Diabetes Devices and Therapeutics Market Size by Oral Anti-Diabetic Drugs, by Value (US$ Million), 2020-2029
Figure 21: India Diabetes Devices and Therapeutics Market Size by Insulin, by Value (US$ Million), 2020-2029
Figure 22: India Diabetes Devices and Therapeutics Market Size by Non-Insulin Injectable Drugs, by Value (US$ Million), 2020-2029
Figure 23: India Diabetes Devices and Therapeutics Market Size by Combination Drugs, by Value (US$ Million), 2020-2029
Figure 24: India Diabetes Devices and Therapeutics Market Share by Oral Anti-Diabetic Drugs (%), 2020-2029
Figure 25: India Diabetes Devices and Therapeutics Market Size by Alpha-Glucosidase Inhibitors (US$ Million), 2020-2029
Figure 26: India Diabetes Devices and Therapeutics Market Size by DPP-4 Inhibitors (US$ Million), 2020-2029
Figure 27: India Diabetes Devices and Therapeutics Market Size by SGLT-2 Inhibitors (US$ Million), 2020-2029
Figure 28: India Diabetes Devices and Therapeutics Market Share by Insulin (%), 2020-2029
Figure 29: India Diabetes Devices and Therapeutics Market Size by Basal or Long-Acting, by Value (US$ Million), 2020-2029
Figure 30: India Diabetes Devices and Therapeutics Market Size by Bolus or Fast-Acting, by Value (US$ Million), 2020-2029
Figure 31: India Diabetes Devices and Therapeutics Market Size by Traditional Human Insulin Drugs, by Value (US$ Million), 2020-2029
Figure 32: India Diabetes Devices and Therapeutics Market Size by Insulin Biosimilars, by Value (US$ Million), 2020-2029
Figure 33: India Diabetes Devices and Therapeutics Market Share by Non-Insulin Injectable Drugs (%), 2020-2029
Figure 34: India Diabetes Devices and Therapeutics Market Size by GLP-1 Receptor Agonists, by Value (US$ Million), 2020-2029
Figure 35: India Diabetes Devices and Therapeutics Market Size by Amylin Analogue, by Value (US$ Million), 2020-2029
Figure 36: India Diabetes Devices and Therapeutics Market Share by Combination Drugs (%), 2020-2029
Figure 37: India Diabetes Devices and Therapeutics Market Size by Combination Insulin, by Value (US$ Million), 2020-2029
Figure 38: India Diabetes Devices and Therapeutics Market Size by Oral Combination, by Value (US$ Million), 2020-2029
Figure 39: India Diabetes Devices and Therapeutics Market Share by Route of Administration (%), 2020-2029
Figure 40: India Diabetes Devices and Therapeutics Market Size by Subcutaneous, by Value (US$ Million), 2020-2029
Figure 41: India Diabetes Devices and Therapeutics Market Size by Intravenous, by Value (US$ Million), 2020-2029
Figure 42: India Diabetes Devices and Therapeutics Market Size by Others, by Value (US$ Million), 2020-2029
Figure 43: India Diabetes Devices and Therapeutics Market Share by Type of Diabetes (%), 2020-2029
Figure 44: India Diabetes Devices and Therapeutics Market Size by Type 2 Diabetes, by Value (US$ Million), 2020-2029
Figure 45: India Diabetes Devices and Therapeutics Market Size by Type 1 Diabetes, by Value (US$ Million), 2020-2029
Figure 46: India Diabetes Devices and Therapeutics Market Share by Distribution Channels (%), 2020-2029
Figure 47: India Diabetes Devices and Therapeutics Market Size by Online Pharmacies, by Value (US$ Million), 2020-2029
Figure 48: India Diabetes Devices and Therapeutics Market Size by Hospital Pharmacies, by Value (US$ Million), 2020-2029
Figure 49: India Diabetes Devices and Therapeutics Market Size by Retail Pharmacies, by Value (US$ Million), 2020-2029
Figure 50: India Diabetes Devices and Therapeutics Market Share by End User (%), 2020-2029
Figure 51: India Diabetes Devices and Therapeutics Market Size by Hospitals, by Value (US$ Million), 2020-2029
Figure 52: India Diabetes Devices and Therapeutics Market Size by Diabetes Clinics, by Value (US$ Million), 2020-2029
Figure 53: India Diabetes Devices and Therapeutics Market Size by Homecare, by Value (US$ Million), 2020-2029
